A recent study finds that the risk for myalgic encephalomyelitis/chronic fatigue syndrome is increased following COVID-19.

Analysis included two control groups: Strict control group (LRTD events negative for RSV, human metapneumovirus, severe acute respiratory syndrome coronavirus 2, and influenza but positive for ...

The Covid-19 outbreak in 2020 was on a scale not seen since the Spanish flu pandemic in 1918 and laid bare our lack of ...

It started as a respiratory illness – or so everyone thought. But it quickly became apparent that SARS-CoV-2, the virus that causes COVID-19, was so much more.

“Newcastle disease is not like severe acute respiratory syndrome. It has been endemic for years and doesn’t affect bird’s nest,” said Mr Tan. “Although chickens and swallows are both ...

InflaRx receives European marketing authorization for Gohibicto treat of SARS-CoV-2-induced acute respiratory distress syndrome: Jena, Germany Friday, January 17, 2025, 11:00 Hrs ...

Chinese billionaire Richard Liu, founder of e-commerce giant JD.com, has pledged to give US$1,400 in cash to each person over ...

To examine the impact of severe acute respiratory syndrome (SARS) on pulmonary function, exercise capacity, and health-related quality of life (HRQoL) among survivors. Conclusion: The exercise ...

Ibudilast is under clinical development by MediciNova and currently in Phase II for Coronavirus Disease 2019 (COVID-19) Associated Acute Respiratory Distress Syndrome. According to GlobalData, Phase ...

It was also under development for the treatment of coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). AptaBio Therapeutics (AptaBio) is a ...